This month’s PNA Spotlight focuses on Dr. Ian Dunn, chairman and a professor of the Department of Neurosurgery at the University of Oklahoma College of Medicine. Dr. Dunn earned his medical degree at Harvard Medical School, then did a postdoctoral fellowship in cancer genomics at Dana-Farber Cancer Institute/Broad Institute in Boston and then a second fellowship in skull base neurosurgery at the University of Arkansas, Little Rock. He did his residency at Children's Hospital/Brigham and Women's Hospital in Boston. He later became an associate professor in the Department of Neurosurgery at Harvard Medical School for eight years and director for the Center for Pituitary and Skull Base Surgery at Brigham and Women’s Hospital. Dr. Dunn was kind enough to respond to a series of questions posed by the PNA; his answers follow.
This month the PNA Medical Corner features and article co-authored by Dr. George Chrousos, a member of the PNA’s Scientific Advisory Panel. The study looks at the process of puberty and the role of various hormones.
Mississauga, ON – January 7, 2020 – Ipsen Biopharmaceuticals Canada Inc. today announced the availability of a new delivery system for Somatuline® Autogel® (lanreotide injection) 60, 90, and 120 mg. The new pre-filled syringe is now available for Canadian patients and includes updated features designed to help make it easier for healthcare providers and patients to administer the injection. Somatuline® Autogel® (lanreotide injection) is approved for the treatment of enteropancreatic neuroendocrine tumours (NETs) in adult patients with Grade 1 or a subset of Grade 2 (equivalent to Ki67<10%) unresectable, locally advanced or metastatic disease, to delay progression;[i]treatment of adult patients with carcinoid syndrome; long-term treatment of patients with acromegaly due to pituitary tumours who have had an inadequate response to or cannot be treated with surgery or radiotherapy.[ii]
Knowledge is power and we believe keeping abreast of news on the research front is imperative. Each month in Highlights we feature a few of the top news stories, which you can read below. In addition, we update our website on a regular basis with the latest breaking news related to pituitary and hormonal disorders by gathering stories we think you'll be interested in from MD Linx, Medscape, MedPage Today, PubMed, Touch Endocrinology, News-Medical.net and WebMD.
Support the PNA
Support the PNA while you shop! Amazon Smile and Goodshop make donations to non profit organizations based on purchases. Click on the images below for information on how you can select the PNA as your charity and earn money for the PNA on all your online purchases.
Disclaimer: PNA does not engage in the practice of medicine. It is not a medical authority, nor does it claim to have medical expertise. In all cases, PNA recommends that you consult your own physician regarding any course of treatment or medication.
Our mailing address is:
Pituitary Network Association
P.O. Box 1958
Thousand Oaks, CA 91358
(805) 499-9973 Phone - (805) 480-0633 Fax
Email [email protected]
You are receiving this Newsletter because you have shown interest in receiving information about our activities.
If you do not want to receive any more emails from PNA, Unsubscribe.
The Pituitary Patient Resource Guide Sixth Edition is now available! Be one of the first to have the most up-to-date information. The Pituitary Patient Resource Guide a one of a kind publication intended as an invaluable source of information not only for patients but also their families, physicians, and all health care providers. It contains information on symptoms, proper testing, how to get a diagnosis, and the treatment options that are available. It also includes Pituitary Network Association's patient resource listings for expert medical care.